Exploring the Pleiotropic Genetic Architecture of Substance Use Disorders: Findings From Phenome-Wide Association Studies.
- 1Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania.
- 2Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
Complex and common, substance use disorders (SUDs) are heterogeneous in presentation and difficult to treat. Moreover, SUDs are frequently comorbid with other psychiatric disorders and medical issues. While it is known that SUDs are moderately heritable, the underlying genetic etiology of SUDs and their comorbidities have remained elusive. Here, we synthesize findings from 2 types of datasets, namely electronic health record-based datasets and deeply phenotyped datasets, to examine genetic liabilities for substance use and associations with other phenotypes. Each dataset type brings unique strengths and limitations to our understanding of the genetics of SUDs. We review phenome-wide association studies of genetic liability for 4 common substances of abuse (alcohol, opioid, tobacco, and cannabis) as well as a transdiagnostic addiction factor. These analyses consistently identified associations with other substances, psychiatric disorders, demographic characteristics, and comorbid medical conditions. We conclude the review by proposing the ideal dataset and future directions for the field.
Related
- Identification of pleiotropic genes and biological mechanisms underlying the shared genetic component between asthma, neuropsychiatric disorders, and substance use behaviors
- An epigenetic candidate–gene association study of parental styles in suicide attempters with substance use disorders
- The Role of Genetic Explanations of Substance Use Disorders in Shaping Stigma in the General Public
- The moderating role of impulsivity in the association between sexual abuse and substance use frequency across countries, gender identities, and sexual orientations
- Factors underlying creativity show distinct genetic architecture and genetic correlations with psychiatric disorders
BibTeX
@article{hartwell2026exploring,
title = {{Exploring the Pleiotropic Genetic Architecture of Substance Use Disorders: Findings From Phenome-Wide Association Studies.}},
author = {Emily E Hartwell and Rachel L Kember},
journal = {Biological psychiatry global open science},
year = {2026},
month = aug,
doi = {10.1016/j.bpsgos.2026.100802},
url = {https://europepmc.org/article/MED/42910298},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Exploring the Pleiotropic Genetic Architecture of Substance Use Disorders: Findings From Phenome-Wide Association Studies.
AU - Emily E Hartwell
AU - Rachel L Kember
PY - 2026
DA - 2026/08/05
JO - Biological psychiatry global open science
DO - 10.1016/j.bpsgos.2026.100802
UR - https://europepmc.org/article/MED/42910298
AB - Complex and common, substance use disorders (SUDs) are heterogeneous in presentation and difficult to treat. Moreover, SUDs are frequently comorbid with other psychiatric disorders and medical issues. While it is known that SUDs are moderately heritable, the underlying genetic etiology of SUDs and their comorbidities have remained elusive. Here, we synthesize findings from 2 types of datasets, namely electronic health record-based datasets and deeply phenotyped datasets, to examine genetic liabilities for substance use and associations with other phenotypes. Each dataset type brings unique strengths and limitations to our understanding of the genetics of SUDs. We review phenome-wide association studies of genetic liability for 4 common substances of abuse (alcohol, opioid, tobacco, and cannabis) as well as a transdiagnostic addiction factor. These analyses consistently identified associations with other substances, psychiatric disorders, demographic characteristics, and comorbid medical conditions. We conclude the review by proposing the ideal dataset and future directions for the field.
SN - 2667-1743
ER -